• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病:过去、现在与未来

Alzheimer's Disease: Past, Present, and Future.

作者信息

Bondi Mark W, Edmonds Emily C, Salmon David P

机构信息

1Department of Psychiatry,University of California San Diego,School of Medicine,La Jolla,California.

3Department of Neurosciences,University of California San Diego,School of Medicine,La Jolla,California.

出版信息

J Int Neuropsychol Soc. 2017 Oct;23(9-10):818-831. doi: 10.1017/S135561771700100X.

DOI:10.1017/S135561771700100X
PMID:29198280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5830188/
Abstract

Although dementia has been described in ancient texts over many centuries (e.g., "Be kind to your father, even if his mind fail him." - Old Testament: Sirach 3:12), our knowledge of its underlying causes is little more than a century old. Alzheimer published his now famous case study only 110 years ago, and our modern understanding of the disease that bears his name, and its neuropsychological consequences, really only began to accelerate in the 1980s. Since then we have witnessed an explosion of basic and translational research into the causes, characterizations, and possible treatments for Alzheimer's disease (AD) and other dementias. We review this lineage of work beginning with Alzheimer's own writings and drawings, then jump to the modern era beginning in the 1970s and early 1980s and provide a sampling of neuropsychological and other contextual work from each ensuing decade. During the 1980s our field began its foundational studies of profiling the neuropsychological deficits associated with AD and its differentiation from other dementias (e.g., cortical vs. subcortical dementias). The 1990s continued these efforts and began to identify the specific cognitive mechanisms affected by various neuropathologic substrates. The 2000s ushered in a focus on the study of prodromal stages of neurodegenerative disease before the full-blown dementia syndrome (i.e., mild cognitive impairment). The current decade has seen the rise of imaging and other biomarkers to characterize preclinical disease before the development of significant cognitive decline. Finally, we suggest future directions and predictions for dementia-related research and potential therapeutic interventions. (JINS, 2017, 23, 818-831).

摘要

尽管痴呆症在数百年前的古代文献中就有记载(例如,“要善待你的父亲,即使他心智衰退。”——《旧约全书》:《西拉书》3:12),但我们对其潜在病因的了解仅有一个多世纪的历史。阿尔茨海默在仅110年前发表了他如今著名的病例研究,而我们对以他名字命名的这种疾病及其神经心理学后果的现代理解,实际上直到20世纪80年代才开始加速发展。从那时起,我们见证了对阿尔茨海默病(AD)和其他痴呆症的病因、特征及可能治疗方法的基础研究和转化研究的激增。我们回顾这一系列工作,从阿尔茨海默自己的著作和绘图开始,然后跳到始于20世纪70年代和80年代初的现代时期,并对随后每个十年的神经心理学及其他相关工作进行抽样介绍。在20世纪80年代,我们的领域开始了对与AD相关的神经心理学缺陷及其与其他痴呆症(如皮质性痴呆与皮质下痴呆)的鉴别进行基础研究。20世纪90年代继续这些努力,并开始确定受各种神经病理底物影响的特定认知机制。21世纪迎来了对神经退行性疾病在全面痴呆综合征(即轻度认知障碍)出现之前的前驱阶段的研究重点。当前这十年见证了成像和其他生物标志物的兴起,以在显著认知衰退出现之前对临床前疾病进行特征描述。最后,我们提出了痴呆症相关研究及潜在治疗干预的未来方向和预测。(《神经影像学杂志》,2017年,第23卷,第818 - 831页)

相似文献

1
Alzheimer's Disease: Past, Present, and Future.阿尔茨海默病:过去、现在与未来
J Int Neuropsychol Soc. 2017 Oct;23(9-10):818-831. doi: 10.1017/S135561771700100X.
2
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.轻度认知障碍阶段阿尔茨海默病的患病率及预后
Brain. 2015 May;138(Pt 5):1327-38. doi: 10.1093/brain/awv029. Epub 2015 Feb 17.
3
Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).血液生物标志物作为有氧运动和认知训练(ACT)治疗反应的替代终点在遗忘型轻度认知障碍中的应用:一项随机对照试验(ACT 试验)的血液生物标志物研究方案。
Trials. 2020 Jan 6;21(1):19. doi: 10.1186/s13063-019-3798-1.
4
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.FDG-PET 和 CSF 生物标志物在大型多中心 MCI 队列中预测向不同类型痴呆转化的准确性。
Neuroimage Clin. 2018 Jan 28;18:167-177. doi: 10.1016/j.nicl.2018.01.019. eCollection 2018.
5
[Awareness disorders in Alzheimer's disease and in mild cognitive impairment].[阿尔茨海默病和轻度认知障碍中的意识障碍]
Encephale. 2014 Apr;40(2):180-7. doi: 10.1016/j.encep.2013.10.003. Epub 2014 Mar 11.
6
The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.阿尔茨海默病所致轻度认知障碍之前的12年:认知衰退的时间性显现
J Alzheimers Dis. 2015;48(4):1095-107. doi: 10.3233/JAD-150137.
7
Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.利用神经心理学过程评分识别细微认知下降并预测向轻度认知障碍的进展。
J Alzheimers Dis. 2018;64(1):195-204. doi: 10.3233/JAD-180229.
8
CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.CERAD 神经心理学复合评分能准确检测前驱期阿尔茨海默病:一项前瞻性 AddNeuroMed 研究。
J Alzheimers Dis. 2014;39(3):679-90. doi: 10.3233/JAD-122110.
9
Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.临床前阿尔茨海默病的轻微认知衰退与生物标志物分期
J Alzheimers Dis. 2015;47(1):231-42. doi: 10.3233/JAD-150128.
10
Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.临床前阿尔茨海默病各阶段皮质和皮质下淀粉样蛋白负荷模式
J Int Neuropsychol Soc. 2016 Nov;22(10):978-990. doi: 10.1017/S1355617716000928.

引用本文的文献

1
Tooth loss impairs cognitive function in SAMP8 mice by aggravating pyroptosis of microglia via the cGAS/STING pathway.牙齿缺失通过cGAS/STING途径加重小胶质细胞的焦亡,从而损害SAMP8小鼠的认知功能。
Front Aging Neurosci. 2025 Aug 22;17:1628520. doi: 10.3389/fnagi.2025.1628520. eCollection 2025.
2
Artificial Intelligence in Alzheimer's Disease Diagnosis and Prognosis Using PET-MRI: A Narrative Review of High-Impact Literature Post-Tauvid Approval.使用PET-MRI进行阿尔茨海默病诊断和预后评估的人工智能:Tauvid获批后高影响力文献的叙述性综述
J Clin Med. 2025 Aug 21;14(16):5913. doi: 10.3390/jcm14165913.
3
Retinal manifestations and their diagnostic significance in Alzheimer's disease.

本文引用的文献

1
Utility of a modified version of the wisconsin card sorting test in the detection of dementia of the alzheimer type.威斯康星卡片分类测试改良版在阿尔茨海默型痴呆检测中的效用
Clin Neuropsychol. 1993 Apr;7(2):161-170. doi: 10.1080/13854049308401518.
2
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.路易体痴呆的诊断与管理:DLB联盟第四次共识报告
Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7.
3
A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages.
阿尔茨海默病的视网膜表现及其诊断意义。
J Alzheimers Dis Rep. 2025 Aug 10;9:25424823251361937. doi: 10.1177/25424823251361937. eCollection 2025 Jan-Dec.
4
Long-term Dietary Fat Intervention Affects Retinal Health in APOE Mice.长期饮食脂肪干预对载脂蛋白E小鼠视网膜健康的影响。
bioRxiv. 2025 Aug 1:2025.07.30.667671. doi: 10.1101/2025.07.30.667671.
5
Saccadic eye movements in neurological disease: cognitive mechanisms and clinical applications.神经疾病中的眼球快速运动:认知机制与临床应用
J Neurol. 2025 Jul 27;272(8):539. doi: 10.1007/s00415-025-13275-x.
6
The MR1/MAIT cell axis impacts the gut-brain axis through both cognition and microbial community structure in 5XFAD mice.在5XFAD小鼠中,MR1/MAIT细胞轴通过认知和微生物群落结构影响肠-脑轴。
Alzheimers Dement. 2025 Jul;21(7):e70493. doi: 10.1002/alz.70493.
7
Antioxidant, Anti-Inflammatory, and Antiapoptotic Effects of Mart. (Açaí) in Improving Cognition Deficits: Potential Therapeutic Implications for Alzheimer's Disease.玛氏(阿萨伊)的抗氧化、抗炎和抗凋亡作用对改善认知缺陷的影响:对阿尔茨海默病的潜在治疗意义
Plants (Basel). 2025 Jun 30;14(13):2010. doi: 10.3390/plants14132010.
8
Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats.通过抗糖尿病药物利拉鲁肽治疗阿尔茨海默病——一项对经脑室内注射链脲佐菌素处理的Wistar大鼠的研究
J Neural Transm (Vienna). 2025 Jul 12. doi: 10.1007/s00702-025-02979-z.
9
Potential role of FNDC5 in exercise-induced improvement of cognitive function.FNDC5在运动诱导的认知功能改善中的潜在作用。
J Zhejiang Univ Sci B. 2025 May 23;26(6):557-572. doi: 10.1631/jzus.B2400016.
10
The Role of Inflammation in Neurodegenerative Diseases: Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis.炎症在神经退行性疾病中的作用:帕金森病、阿尔茨海默病和多发性硬化症。
Int J Mol Sci. 2025 May 28;26(11):5177. doi: 10.3390/ijms26115177.
基于神经影像学的阿尔茨海默病及其前驱期分类研究及相关特征提取方法综述。
Neuroimage. 2017 Jul 15;155:530-548. doi: 10.1016/j.neuroimage.2017.03.057. Epub 2017 Apr 13.
4
Tau Imaging in Alzheimer's Disease Diagnosis and Clinical Trials.阿尔茨海默病诊断与临床试验中的tau蛋白成像
Neurotherapeutics. 2017 Jan;14(1):62-68. doi: 10.1007/s13311-016-0490-y.
5
Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria.轻度认知障碍中异质性皮质萎缩模式未被传统诊断标准所捕捉。
Neurology. 2016 Nov 15;87(20):2108-2116. doi: 10.1212/WNL.0000000000003326. Epub 2016 Oct 19.
6
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.A/T/N:阿尔茨海默病生物标志物的无偏描述性分类方案。
Neurology. 2016 Aug 2;87(5):539-47. doi: 10.1212/WNL.0000000000002923. Epub 2016 Jul 1.
7
Suspected non-Alzheimer disease pathophysiology--concept and controversy.疑似非阿尔茨海默病的病理生理学——概念与争议
Nat Rev Neurol. 2016 Feb;12(2):117-24. doi: 10.1038/nrneurol.2015.251. Epub 2016 Jan 18.
8
Defining the Genetic Architecture of Alzheimer's Disease: Where Next.定义阿尔茨海默病的遗传结构:下一步何去何从。
Neurodegener Dis. 2016;16(1-2):6-11. doi: 10.1159/000440841. Epub 2015 Nov 10.
9
Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.临床前阿尔茨海默病的轻微认知衰退与生物标志物分期
J Alzheimers Dis. 2015;47(1):231-42. doi: 10.3233/JAD-150128.
10
The preclinical phase of the pathological process underlying sporadic Alzheimer's disease.散发性阿尔茨海默病病理过程的临床前期。
Brain. 2015 Oct;138(Pt 10):2814-33. doi: 10.1093/brain/awv236. Epub 2015 Aug 17.